Become A Wiser, More Profitable Investor

✅   Drug-Drug Interactions in Transgender Patients Receiving Antiretroviral and Hormonal Therapy: A Systematic Review of Clinical Studies and Reports

science

Transgender individuals, whose gender identity differs from their assigned sex at birth, often undergo pharmacotherapy, including hormone therapy (HT), as part of their gender-affirming care. This pharmacotherapy, particularly when combined with antiretroviral therapy (ART) for transgender individuals living with HIV, raises concerns about drug-drug interactions (DDIs). These interactions can alter treatments' efficacy and lead to adverse health outcomes, making understanding their nature and...

NCBI     Apr 11, 2025